CareTrust REIT, Inc. (CTRE) P/E Ratio History
Deep ValueTrading at 23.6x · 10th percentile of 5-year range · Significant discount to historical valuation · Data 2015–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, CareTrust REIT, Inc. (CTRE) trades at a price-to-earnings ratio of 23.6x, with a stock price of $37.06 and trailing twelve-month earnings per share of $1.50.
The current P/E is 87% below its 5-year average of 176.5x. Over the past five years, CTRE's P/E has ranged from a low of 23.0x to a high of 1844.0x, placing the current valuation at the 10th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.1x, CTRE is roughly in line with its sector peers. The sector includes 174 companies with P/E ratios ranging from 0.7x to 195.6x.
The PEG ratio of 1.11 (P/E divided by 96% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, CTRE trades roughly in line with the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CTRE DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CTRE Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CTRE P/E vs Peers
Senior housing and skilled nursing peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 28.3 | - | +19% | |
| $2B | 14.4Lowest | - | +24% | |
| $94M | 115.3 | - | -394% | |
| $498M | 225.2 | - | +134% | |
| $13B | 23.0 | 0.98Best | +25% | |
| $39B | 151.1 | - | +184%Best | |
| $145B | 148.7 | - | -11% | |
| $14B | 195.6 | - | -72% | |
| $3B | 23.5 | - | -4% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CTRE Historical P/E Data (2015–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $36.65 | $1.58 | 23.2x | -78% |
| FY2025 Q4 | Dec 31 2025 | $36.16 | $1.57 | 23.0x | -78% |
| FY2025 Q3 | - | $34.68 | $1.34 | 25.9x | -75% |
| FY2025 Q2 | Jun 30 2025 | $30.60 | $1.20 | 25.5x | -75% |
| FY2025 Q1 | Mar 31 2025 | $28.58 | $0.92 | 31.1x | -70% |
| FY2024 Q4 | - | $27.05 | $0.79 | 34.2x | -67% |
| FY2024 Q3 | Sep 30 2024 | $30.86 | $0.73 | 42.0x | -59% |
| FY2024 Q2 | Jun 30 2024 | $25.10 | $0.60 | 41.5x | -60% |
| FY2024 Q1 | Mar 31 2024 | $24.37 | $0.53 | 46.0x | -56% |
| FY2023 Q4 | Dec 31 2023 | $22.38 | $0.50 | 44.8x | -57% |
| FY2023 Q3 | Sep 30 2023 | $20.50 | $0.31 | 65.2x | -37% |
| FY2023 Q2 | Jun 30 2023 | $19.86 | $0.16 | 128.0x | +24% |
| FY2023 Q1 | Mar 31 2023 | $19.58 | $0.37 | 52.9x | -49% |
| FY2022 Q2 | - | $18.44 | $0.01 | 1844.0x | +1681% |
| FY2022 Q1 | - | $19.30 | $0.02 | 965.0x | +832% |
| FY2021 Q4 | Dec 31 2021 | $22.83 | $0.74 | 30.9x | -70% |
| FY2021 Q3 | - | $20.32 | $0.77 | 26.4x | -75% |
| FY2021 Q2 | Jun 30 2021 | $23.23 | $0.88 | 26.4x | -75% |
| FY2021 Q1 | Mar 31 2021 | $23.29 | $0.86 | 27.1x | -74% |
| FY2020 Q4 | - | $22.18 | $0.85 | 26.1x | -75% |
| FY2020 Q3 | Sep 30 2020 | $17.80 | $0.85 | 20.9x | -80% |
| FY2020 Q2 | - | $17.16 | $0.51 | 33.6x | -68% |
| FY2020 Q1 | - | $14.79 | $0.52 | 28.4x | -73% |
| FY2019 Q4 | - | $20.63 | $0.50 | 41.3x | -60% |
| FY2019 Q3 | Sep 30 2019 | $23.51 | $0.46 | 51.1x | -51% |
| FY2019 Q2 | Jun 30 2019 | $23.78 | $0.75 | 31.7x | -69% |
| FY2019 Q1 | Mar 31 2019 | $23.46 | $0.71 | 33.0x | -68% |
| FY2018 Q4 | Dec 31 2018 | $18.46 | $0.72 | 25.6x | -75% |
| FY2018 Q3 | Sep 30 2018 | $17.71 | $0.57 | 31.1x | -70% |
| FY2018 Q2 | Jun 30 2018 | $16.69 | $0.54 | 30.9x | -70% |
| FY2018 Q1 | Mar 31 2018 | $13.40 | $0.40 | 33.7x | -67% |
| FY2017 Q4 | Dec 31 2017 | $16.76 | $0.36 | 46.8x | -55% |
| FY2017 Q3 | Sep 30 2017 | $19.04 | $0.47 | 40.7x | -61% |
| FY2017 Q2 | Jun 30 2017 | $18.54 | $0.46 | 40.5x | -61% |
| FY2017 Q1 | Mar 31 2017 | $16.82 | $0.56 | 30.0x | -71% |
| FY2016 Q4 | Dec 31 2016 | $15.32 | $0.52 | 29.5x | -72% |
| FY2016 Q3 | Sep 30 2016 | $14.78 | $0.48 | 30.8x | -70% |
| FY2016 Q2 | - | $13.78 | $0.36 | 38.4x | -63% |
| FY2016 Q1 | - | $12.70 | $0.30 | 42.2x | -59% |
| FY2015 Q4 | - | $10.95 | $0.26 | 42.8x | -59% |
| FY2015 Q3 | Sep 30 2015 | $11.35 | $0.18 | 64.4x | -38% |
| FY2015 Q2 | - | $12.67 | $0.25 | 51.7x | -50% |
Average P/E for displayed period: 103.5x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CTRE — Frequently Asked Questions
Quick answers to the most common questions about buying CTRE stock.
What is CTRE's P/E ratio?
CareTrust REIT, Inc. (CTRE) trailing twelve-month P/E ratio is 23.6x, based on TTM diluted EPS of $1.50. The 5-year average P/E is 176.5x and the historical range spans 23.0x to 1844.0x.
Is CTRE stock overvalued or undervalued?
CTRE trades at 23.6x P/E, below its 5-year average of 176.5x. At the 10th percentile of its historical range (23.0x–1844.0x), the stock is priced at a discount to its own history.
Is CTRE stock expensive?
No, CTRE is not expensive on a historical basis. The current P/E of 23.6x is below the 5-year average of 176.5x and sits at the 10th percentile of its valuation range.
What is CTRE's historical P/E range?
Over the past 5 years, CTRE's P/E ratio has ranged from 23.0x to 1844.0x, with a median of 34.2x and an average of 176.5x. The current P/E of 23.6x places the stock at the 10th percentile of this range. Full historical data spans 2015–2026.
How does CTRE's P/E compare to the S&P 500?
CTRE trades at 23.6x P/E versus the S&P 500 median of 24.4x. The 3% discount to the market suggests lower growth expectations or perceived higher risk.
How does CTRE's valuation compare to Real Estate peers?
CareTrust REIT, Inc. P/E of 23.6x compares to the Real Estate sector median of 24.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is CTRE's PEG ratio?
CTRE PEG ratio is 1.11, based on a P/E of 23.6x and EPS growth of 96.3%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is CTRE's earnings yield?
CTRE earnings yield is 4.24%, the inverse of its 23.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.